Piper Sandler Maintains Neutral on Exact Sciences, Raises Price Target to $90
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst David Westenberg maintains a Neutral rating on Exact Sciences (NASDAQ:EXAS) and raises the price target from $80 to $90.
August 08, 2023 | 7:11 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Piper Sandler maintains a Neutral rating on Exact Sciences and raises the price target from $80 to $90. This could potentially attract investors.
The raised price target by Piper Sandler indicates a positive outlook for Exact Sciences. This could potentially attract investors and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100